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httpThe beneﬁt of early repair for a mycotic aortic
aneurysm due to Yersinia enterocolitica infection
Hari R. Kumar, MD, and Mark K. Eskandari, MD, Chicago, Ill
Mycotic aortic aneurysms are infrequent but challenging cases. We present a 68-year-old man with evolving infrarenal
aortic and right common iliac artery aneurysms from an infection with Yersinia enterocolitica. This is a rare but virulent
cause of aortitis. The patient underwent open resection and debridement with anatomic reconstruction using an aortic
homograft. He recovered well and quickly returned to normal functional status. This represents the ﬁrst successful
anatomic aortic repair using homograft with this organism. Here, we review the literature and outcomes associated
with this unusual pathogen. With favorable anatomy and expedient operative management, good results can be
obtained. (J Vasc Surg Cases 2015;1:61-4.)The term mycotic aneurysm was ﬁrst introduced by Sir
William Osler in 1885 to describe secondary infections of
the vascular system caused by bacterial endocarditis.1 In
current usage, the term applies to any aneurysm of infec-
tious origin. The etiology and pathogens have evolved
over the years to include more aggressive organisms. For
vascular surgeons, this disease process remains difﬁcult to
treat due to the fragile patient population and the complex
repairs that are often required. Even with aggressive surgi-
cal care, the mortality remains high. The patient provided
consent for the publication of his case report.
CASE REPORT
The patient was a 68-year-old man with only a history of
discoid (cutaneous) lupus erythematosus who emigrated from
Eastern Europe 4 years earlier. He presented to another hospital
with fevers to 103F and signiﬁcant back pain of 4 days’ duration.
He denied any gastrointestinal symptoms.
Laboratory tests revealed leukocytosis of 16,000/mm3, and
blood cultures grew gram-negative bacilli. A computed tomogra-
phy (CT) scan with intravenous contrast demonstrated inﬂamma-
tion of the infrarenal aorta and a small aneurysm along the
posterior wall with an aortic diameter of 2.8 cm (Fig 1). The pa-
tient was given intravenous piperacillin-tazobactam and transferred
to our tertiary care institution.
On arrival, his fevers, leukocytosis, and bacteremia had
resolved; however, he had persistent back pain. A CT angiogram
performed 2 days after arrival demonstrated progression of his
aortic disease, with interval enlargement of the initial posteriorthe Division of Vascular Surgery, Northwestern University Feinberg
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mation into new aneurysms (Fig 1). Final results of the blood cul-
tures from the other hospital showed Yersinia enterocolitica. The
patient was then taken for open operative repair.
Exploratory laparotomy revealed ﬁbrosis in the terminal ileum,
with normal appearance of the remaining small and large intestine,
appendix, and gallbladder. Exploration of the retroperitoneum
revealed a normal duodenum but signiﬁcant inﬂammation of the
infrarenal aorta. The infrarenal aorta and common iliac arteries
were clamped after systemic heparinization, and the aorta was
opened lengthwise. Two pockets of purulent material were evacu-
ated, and a contained rupture of the posterior aortic wall was
discovered at the site of the enlarging mycotic aneurysm (Fig 2).
All clinically apparent infected and inﬂamed aortic and retroperito-
neal tissues were debrided until only visually healthy tissue
remained.
An anatomic reconstruction was performed (Fig 3) from the
infrarenal aorta to the common iliac arteries using a cryopreserved
cadaveric aortoiliac homograft (CryoLife Inc, Kennesaw, Ga). Two
closed suction drains were left near the aorta. An omental pedicle
was mobilized and used to cover the entire repair.
After the operation the patient fared well. Intraoperative cul-
tures were positive for Y enterocolitica. Results of postoperative
blood and urine cultures were negative. He was discharged to
home on postoperative day 7. He was treated with 6 weeks of
intravenous ceftriaxone and 2 weeks of oral metronidazole. The
patient was seen in the clinicw6 weeks after repair, with no com-
plaints, and a subsequent CT scan did not demonstrate any evi-
dence of residual or recurrent infection. The drains were
removed, and he was prescribed a long-term oral suppressive
regimen of trimethoprim and sulfamethoxazole.
DISCUSSION
Mycotic aneurysms of the aorta represent an infrequent
indication for aortoiliac reconstruction, with contemporary
series having an incidence of 0.7% to 2.4% among all open
thoracoabdominal or abdominal aortic repairs.2-4 Manage-
ment of these patients is quite challenging because these
often occur in patients who are immunocompromised or
have other comorbid conditions (70%), involve segments
other than the infrarenal aorta (60%-80%), and have61
Fig 1. Left, Images are from the initial computed tomography (CT) scan at another hospital. Right, Images represent
similar sections from our subsequent preoperative CT angiography done 48 hours later. The arrows demonstrate areas
of progression of inﬂammation and aneurysmal degeneration seen at (A) the distal aorta on sagittal view, (B) the aortic
bifurcation on axial view, (C) and the right common iliac on axial view.
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(50%-85%).
Most patients are symptomatic at presentation,
although the nonspeciﬁc nature of the symptoms (fever,
back pain) requires a high index of suspicion. These symp-
toms are often accompanied by other ﬁndings, including
bacteremia, leukocytosis, elevated sedimentation rate, and
occasionally, a pulsatile mass. CT ﬁndings include inﬂam-
mation and aneurysmal changes of the aorta.
The organisms responsible for mycotic aneurysms have
changed during the past century from gram-positive infec-
tions secondary to bacterial endocarditis to now predomi-
nantly Staphylococcus aureus and Salmonella spp. Infections
with gram-negative bacilli appear to be particularly aggres-
sive, with the risk of rupture >80% at 2 weeks from time of
diagnosis.5 The bacteria isolated from our patient, Y entero-
colitica, is a rare cause of mycotic aortic aneurysm.
Y enterocolitica is a gram-negative bacillus that, when
infectious, typically causes gastrointestinal symptoms such
as abdominal pain, emesis, and bloody diarrhea.6,7 There
are two other pathogenic Yersinia spp: Y pseudotuberculosis
causes similar gastrointestinal symptoms, and Y pestis is an
agent responsible for the plague. Y enterocolitica is not
native to normal human ﬂora but can be transmitted
through contact with animals or ingestion of undercookedmeat. It is an uncommon cause of illness in the United
States, with cases more frequently reported worldwide.
Why our patient did not present with recent gastrointes-
tinal symptoms or how our patient acquired this infection
is unclear, because he denied recent exposure to animals,
ingestion of uncooked meat, or travel abroad.
Previous reports within the literature have described 12
primary or secondary cases of aortic infections due to
Y enterocolitica. The perioperative mortality in these cases
was 66%.7-15 Mycotic aneurysms of other peripheral
vascular territories, including the carotid and lower extrem-
ity, have been described with this organism and are equally
rare.7,10,16
Traditional teaching regarding repair of mycotic
infrarenal aneurysms has included aneurysm resection, peri-
vascular soft tissue debridement, oversewing of the infrare-
nal aortic stump, extra-anatomic reconstruction to avoid
the infected ﬁeld, and long-term antibiotic treatment.
The advantage of this approach is that it can be performed
in a staged fashion, and the bypass is performed outside of
the infected ﬁeld.
Contamination in our patient was limited, and all
visibly infected tissue was removed. A healthy cuff of
infrarenal aorta and bilateral common iliac artery was
obtained. In this setting, we prefer to use an anatomic
Fig 2. Intraoperative photograph shows contained rupture of
mycotic aneurysm (blue arrow). The aorta has been clamped and
opened lengthwise along the infrarenal segment, and the cavity is
visible along the posterior wall. Fig 3. Intraoperative photograph shows completed anatomic
repair.
JOURNAL OF VASCULAR SURGERY CASES
Volume 1, Number 1 Kumar and Eskandari 63reconstruction with an aortic homograft. This reduces
operative time and eliminates the concern for rupture of
the aortic stump seen with extra-anatomic repairs. The lim-
itations of homograft include its expense and availability;
although at our institution, we are fortunate to have a sup-
ply of grafts kept in frozen storage for such occasions. A
recent multicenter series of aortic reconstruction using
homograft for a variety of infectious conditions showed
excellent long-term results.17 For mycotic aneurysms,
other centers have also had good success in anatomic
reconstructions using an antibiotic-soaked prosthetic graft2
or autologous deep femoral vein.18,19
Historically, mycotic aneurysms were thought to be a
relatively fatal condition.20 Although the modern approach
has signiﬁcantly improved the mortality rate, it remains
high, at 21% to 36%, within the perioperative period
alone.2,3 A particular subset of patients does better with
intervention. A recent review of our institutional data on
small mycotic aneurysms (<4 cm aortic diameter) demon-
strated a perioperative mortality of 0%, with a 90% survival
at 23 months.4
Our patient was fortunate to have had small aneurysms in
favorable locations. However, the radiographic progression of
his aortic disease was quite concerning. In reviewing the casesof mycotic aneurysm associated with Y enterocolitica,many of
the patients had large aneurysms with friable, poor-quality
aortic tissue leading tomassivehemorrhageat the timeof repair.
CONCLUSIONS
We continue to advocate early surgical repair when a
diagnosis of mycotic aneurysm is made, because progres-
sion of disease makes surgery increasingly complicated. In
the setting of limited contamination, with adequate resec-
tion and debridement, an anatomic repair with aortic
homograft can have good results.REFERENCES
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